Mesopancreatic excision for pancreatic ductal adenocarcinoma improves local disease control and survival

Kausch, 1912, Das Carcinom der Papilla duodeni und seine radikale Entfernung, Beitr Klin Chir, 78, 439 Whipple, 1935, Treatment OF carcinoma OF the ampulla OF vater, Ann Surg, 102, 763, 10.1097/00000658-193510000-00023 Kenner, 2016, Early detection of pancreatic cancer: a defined future using lessons from other cancers: a white paper, Pancreas, 1073–9 Rahib, 2014, Projecting cancer incidence and deaths to 2030: the unexpected burden of thyroid, liver, and pancreas cancers in the United States, Canc Res, 74, 2913, 10.1158/0008-5472.CAN-14-0155 Carrato, 2015, A systematic review of the burden of pancreatic cancer in Europe: real-world impact on survival, quality of life and costs, J Gastrointest Canc, 46, 201, 10.1007/s12029-015-9724-1 Neoptolemos, 2017, Comparison of adjuvant gemcitabine and capecitabine with gemcitabine monotherapy in patients with resected pancreatic cancer (ESPAC-4): a multicentre, open-label, randomised, phase 3 trial, Lancet (London, England), 389, 1011, 10.1016/S0140-6736(16)32409-6 Malleo, 2020, Does site matter? Impact of tumor location on pathologic characteristics, recurrence, and survival of resected pancreatic ductal adenocarcinoma, Ann Surg Oncol, 27, 3898, 10.1245/s10434-020-08354-4 Mee Joo Kang, 2016, Surgical resection of pancreatic head cancer: what is the optimal extent of surgery?, Canc Lett, 259, 10.1016/j.canlet.2016.01.042 Sinn, 2017, CONKO-005: adjuvant chemotherapy with gemcitabine plus Erlotinib versus gemcitabine alone in patients after R0 phase III trial, J Clin Oncol, 3330, 10.1200/JCO.2017.72.6463 Conroy, 2018, FOLFIRINOX or gemcitabine as adjuvant therapy for pancreatic cancer, N Engl J Med, 379, 2395, 10.1056/NEJMoa1809775 Verbeke, 2006, Redefining the R1 resection in pancreatic cancer, Br J Surg, 93, 1232, 10.1002/bjs.5397 Esposito, 2008, Most pancreatic cancer resections are R1 resections, Ann Surg Oncol, 1651, 10.1245/s10434-008-9839-8 Schlitter, 2010, Definition of microscopic tumor clearance (R0) in pancreatic cancer resections, Cancers, 2, 2001, 10.3390/cancers2042001 Häberle, 2020, Circumferential resection margin (CRM) in pancreatic cancer, Surg Pract Sci, 1, 100006, 10.1016/j.sipas.2020.100006 Weitz, 2010, The "artery first" approach for resection of pancreatic head cancer, J Am Coll Surg, 210, e1, 10.1016/j.jamcollsurg.2009.10.019 Hackert, 2010, Uncinate process first--a novel approach for pancreatic head resection, Langenbeck’s Arch Surg, 395, 1161, 10.1007/s00423-010-0663-9 Fortner, 1977, Regional pancreatectomy: en bloc pancreatic, portal vein and lymph node resection, Ann Surg, 186, 42, 10.1097/00000658-197707000-00007 Bausch, 2018, Minimally invasive surgery of pancreatic cancer: feasibility and rationale, Visc Med, 34, 440, 10.1159/000495324 Inoue, 2015, Pancreatoduodenectomy with systematic mesopancreas dissection using a supracolic anterior artery-first approach, Ann Surg, 262, 1092, 10.1097/SLA.0000000000001065 Jang, 2014, A prospective randomized controlled study comparing outcomes of standard resection and extended resection, including dissection of the nerve plexus and various lymph nodes, in patients with pancreatic head cancer, Ann Surg, 259, 656, 10.1097/SLA.0000000000000384 Rau, 2012, R1 resection in pancreatic cancer has significant impact on long-term outcome in standardized pathology modified for routine use, Surgery, 152, S103, 10.1016/j.surg.2012.05.015 Niesen, 2019, Local radicality and survival outcome of pancreatic cancer surgery, Ann Gastroenterol Surg, 3, 464, 10.1002/ags3.12273 Sabater, 2019, Does the artery-first approach improve the rate of R0 resection in pancreatoduodenectomy?: a multicenter, randomized, controlled trial, Ann Surg, 270, 738, 10.1097/SLA.0000000000003535 Cong, 2018, Tumor size classification of the 8(th) edition of TNM staging system is superior to that of the 7(th) edition in predicting the survival outcome of pancreatic cancer patients after radical resection and adjuvant chemotherapy, Sci Rep, 8, 10383, 10.1038/s41598-018-28193-4 Seufferlein, 2013, [S3-guideline exocrine pancreatic cancer], Z. Gastroenterol., 51, 1395 Gockel, 2007, Resection of the mesopancreas (RMP): a new surgical classification of a known anatomical space, World J Surg Oncol, 5, 44, 10.1186/1477-7819-5-44 Popescu, 2018, What is the value of total mesopancreas excision in pancreatic ductal adenocarcinoma? Current evidence of the literature, Chirurgia (Bucharest, Romania, 113, 335, 10.21614/chirurgia.113.3.335 Nappo, 2016, The standardization of pancreatoduodenectomy: where are we?, Pancreas, 45, 493, 10.1097/MPA.0000000000000503 Peparini, 2013, Mesopancreas: a boundless structure, namely R1 risk in pancreaticoduodenectomy for pancreatic head carcinoma, Eur J Surg Oncol : J Eur Soc Surg Oncol Br Assoc Surg Oncol, 39, 1303, 10.1016/j.ejso.2013.10.012 Kurosaki, 2011, Left posterior approach to the superior mesenteric vascular pedicle in pancreaticoduodenectomy for cancer of the pancreatic head, JOP : J Pancreas, 12, 220 Strobel, 2017, Pancreatic cancer surgery: the new R-status counts, Ann Surg, 265, 565, 10.1097/SLA.0000000000001731 Demir, 2018, R0 versus R1 resection matters after pancreaticoduodenectomy, and less after distal or total pancreatectomy for pancreatic cancer, Ann Surg, 268, 1058, 10.1097/SLA.0000000000002345 Dusch, 2020, Intensified histopathological work-up after pancreatic head resection reveals relevant prognostic markers, Digestion, 1 Sperti, 1997, Recurrence after resection for ductal adenocarcinoma of the pancreas, World J Surg, 21, 195, 10.1007/s002689900215 Hishinuma, 2006, Patterns of recurrence after curative resection of pancreatic cancer, based on autopsy findings, J Gastrointest Surg : Off J Soc Surg Aliment Tract, 10, 511, 10.1016/j.gassur.2005.09.016 Van den Broeck, 2009, Patterns of recurrence after curative resection of pancreatic ductal adenocarcinoma, Eur J Surg Oncol : J Eur Soc Surg Oncol Br Assoc Surg Oncol, 35, 600, 10.1016/j.ejso.2008.12.006 Groot, 2017, Systematic review on the treatment of isolated local recurrence of pancreatic cancer after surgery; re-resection, chemoradiotherapy and SBRT, HPB : Off J Int Hepato Pancreato Biliary Assoc, 19, 83, 10.1016/j.hpb.2016.11.001 Tummers, 2019, Impact of resection margin status on recurrence and survival in pancreatic cancer surgery, Br J Surg, 106, 1055, 10.1002/bjs.11115 Tanaka, 2019, Meta-analysis of recurrence pattern after resection for pancreatic cancer, Br J Surg, 106, 1590, 10.1002/bjs.11295 Groot, 2019, Recurrence after neoadjuvant therapy and resection of borderline resectable and locally advanced pancreatic cancer, Eur J Surg Oncol : J Eur Soc Surg Oncol Br Assoc Surg Oncol, 45, 1674, 10.1016/j.ejso.2019.04.007 Rehders, 2012, Vascular invasion in pancreatic cancer: tumor biology or tumor topography?, Surgery, 152, S143, 10.1016/j.surg.2012.05.012